NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Stock Report

Market Cap: US$2.6m

NovaBay Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NBY?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4700.00962%
Private Companies4,2350.0867%
Institutions126,3942.59%
General Public4,754,59497.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2519%.

Top Shareholders

Top 24 shareholders own 2.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.88%
C2C Wealth Management, LLC
42,948US$22.8k0%0.02%
0.54%
Geode Capital Management, LLC
26,337US$14.0k3,580%no data
0.43%
UBS Asset Management AG
21,062US$11.2k158%no data
0.4%
Virtu Financial LLC, Asset Management Arm
19,590US$10.4k0%no data
0.2%
Warberg Asset Management LLC
10,000US$5.3k0%0.02%
0.11%
Tower Research Capital Europe Limited
5,481US$2.9k66.4%no data
0.087%
Tian Tian Limited
4,235US$2.2k0%no data
0.01%
Morgan Stanley, Investment Banking and Brokerage Investments
503US$266.716,700%no data
0.008%
The Vanguard Group, Inc.
391US$207.10%no data
0.0016%
Paul Freiman
77US$40.90%no data
0.0015%
Yenyou Zheng
75US$39.90%no data
0.0015%
Mijia Wu
75US$39.90%no data
0.0015%
Swan Sit
75US$39.90%no data
0.0014%
Justin Hall
68US$36.00%no data
0.001%
Julie Garlikov
50US$26.40%no data
0.001%
Yongxiang Zheng
50US$26.40%no data
0.00086%
Bank of America Corporation, Asset Management Arm
42US$22.30%no data
0.00063%
Blackstone Alternative Investment Advisors LLC
31US$16.3-108%no data
0.00006%
NVWM LLC
3US$1.60%no data
0.00004%
Thrivent Trust Company, Asset Management Arm
2US$1.0-94.6%no data
0.00002%
RBC Dominion Securities Inc., Asset Management Arm
1US$0.50%no data
0.00002%
Securities America Advisors, Inc.
1US$0.50%no data
0.00002%
Northwestern Mutual Wealth Management Company
1US$0.50%no data
0.00002%
Addison Advisors LLC
1US$0.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NovaBay Pharmaceuticals, Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Stephen DunnDawson James Securities
Pooya HemamiDesjardins Securities Inc.